Search Results
Dec 22, 2025, 07:00 ET U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
with immunomodulatory and antifibrotic effects approved in this indication.1,5 The FDA approval is based on results from the pivotal Phase III FIBRONEERTM-ILD clinical trial, the largest clinical trial program in PPF to date.5 Results showed that JASCAYD effectively slowed
More news about: Boehringer Ingelheim
Dec 22, 2025, 06:00 ET The9 Limited Announces Result of Annual General Meeting
ordinary resolution, that Mr. Zhu Jun, whose term of office shall expire on the date of this Annual General Meeting, be re-elected and appointed as a Class III Director of the Company, effective from the closing of this Annual General Meeting, to serve for a three (3) year term ending at the 2028 Annual General
More news about: The9 Limited
Dec 22, 2025, 05:07 ET AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B
oligonucleotide therapies for functional cure of chronic hepatitis B (CHB), today announced the completion of patient enrollment in its Phase III AUSHINE clinical trial (CTR20252792/ NCT07246889).
More news about: AusperBio Therapeutics Inc.
Dec 22, 2025, 04:00 ET Shareholders that lost money on Skye Bioscience, Inc.(SKYE) should contact The Gross Law Firm about pending Class Action - SKYE
effective than defendants had led investors to believe; (ii) accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: January 16, 2026 Shareholders
More news about: The Gross Law Firm
Dec 22, 2025, 04:00 ET The Gross Law Firm Reminds DeFi Technologies Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 30, 2026 - DEFT
treasury companies and the extent to which that competition would negatively impact its ability to execute its DeFi arbitrage strategy; (iii) as a result of the foregoing issues, the Company was unlikely to meet its previously issued revenue guidance for the fiscal year 2025; (iv) accordingly,
More news about: The Gross Law Firm
Dec 22, 2025, 04:00 ET The Gross Law Firm Notifies Shareholders of Firefly Aerospace Inc.(FLY) of a Class Action Lawsuit and an Upcoming Deadline
for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the offering documents and defendants'
More news about: The Gross Law Firm
Dec 22, 2025, 04:00 ET DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - DXCM
and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (iii) accordingly, defendants' purported enhancements to the G7, as well as the device's reliability, accuracy, and functionality, were overstated; (iv) defendants
More news about: The Gross Law Firm
Dec 21, 2025, 17:43 ET Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK
record of operational and construction excellence through on-time completion of its Bio Campus I and II, and also recently secured land for Bio Campus III, which will house distinct R&D and manufacturing programs for new modalities. With 785,000 liters of capacity across five plants, the industry's
More news about: Samsung Biologics
Dec 19, 2025, 23:05 ET STUB INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that StubHub Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
timing of payments to vendors; (ii) those changes had a significant adverse impact on free cash flow, including trailing 12 months free cash flow; and (iii) as a result, StubHub's free cash flow reports were materially misleading. The quarterly report allegedly revealed that this year-over-year
More news about: Robbins Geller Rudman & Dowd LLP
Dec 19, 2025, 22:55 ET Jayud Global Logistics Ltd. Notice of January 19, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
(ii) insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; (iii) the Company's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity elevating the stock price;
More news about: Kahn Swick & Foti, LLC
Dec 19, 2025, 22:51 ET Six Flags Entertainment Corporation Securities Fraud Class Action Result of Undisclosed Financial Problems and 63% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
cost-cutting measures, including significant reductions in employee headcount, which materially degraded operational competence and guest experience; (iii) as a result, Legacy Six Flags required a substantial and undisclosed capital infusion to stabilize and revitalize its business, and these acute capital
More news about: Kahn Swick & Foti, LLC
Dec 19, 2025, 22:11 ET Freeport McMoRan Inc. Investors (FCX) with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
(ii) the lack of proper safety precautions constituted a heightened risk that could foreseeably lead to the death of Freeport-McMoRan's workers; and (iii) this constituted an undisclosed heightened risk of regulatory, litigation, and reputational risk.The Freeport-McMoRan class action lawsuit
More news about: Robbins Geller Rudman & Dowd LLP
Dec 19, 2025, 19:06 ET BRC Therapeutics Applauds Executive Order to Reclassify Cannabis
as more dangerous than others, the so-called Schedule I drugs under the Controlled Substances Act. Cannabis' classification would become a Schedule III drug.
More news about: BRC Therapeutics
Dec 19, 2025, 18:00 ET Baker University Provides Notice of a Data Security Event
individuals may need to provide some or all of the following information:Full name (including middle initial as well as Jr., Sr., II, III, etc.);Social Security number;Date of birth;Addresses for the prior two to five years;Proof of current address, such
More news about: Baker University
Dec 19, 2025, 17:00 ET Wheels Up Receives NYSE Continued Listing Standard Notice
effecting the Potential Reverse Split with respect to the Common Stock or any other action intended to cure compliance with Section 802.01C, or at all; (iii) the availability or success of other options that the Company may undertake that are intended to cure compliance with Section 802.01C; (iv) Wheels Up's
More news about: Wheels Up
Dec 19, 2025, 14:37 ET Bitmine Invites Stockholders to Attend its Annual Meeting Held in Las Vegas on January 15, 2026; Encourages Stockholders to Cast Their Votes
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: BitMine Immersion Technologies, Inc.
Dec 19, 2025, 11:23 ET Presidential Executive Order Validates DeFloria's Strategy in Pharmaceutical Cannabinoid Drug Development
- DeFloria Inc., a botanical drug development Company recognizes the Presidential Executive Order to reclassify cannabis from Schedule I to Schedule III, as a critical accelerator for cannabinoid medical innovation and regulatory reform. DeFloria is advancing a leading cannabinoid-based investigational
More news about: Charlotte's Web Holdings, Inc.
Dec 19, 2025, 10:05 ET Grand Rapids Community College Names Dr. Kathryn Rogalski 12th President
transition from traditional 15-week semesters to eight-week semesters to improve persistence and completion, securing a $2.25 million federal Title III grant to expand high-impact teaching practices, and strengthening partnerships with K-12 districts, universities and employers.Prior to NWTC,
More news about: Grand Rapids Community College
Dec 19, 2025, 10:00 ET ZIEGLER CLOSES $53,800,000 FINANCING FOR MEADOWLARK HILLS (KS)
available funds, will be used to (i) fund project costs of The Aster, (ii) fund interest on the bonds for a period of 26 months (construction + 3 months), (iii) fund a deposit to the Master Reserve Fund for the 2025A Bonds, and (iv) pay costs of issuance. The 2025B Bonds do not have a debt service reserve fund.
More news about: Ziegler
Dec 19, 2025, 09:15 ET CARNIVAL CORPORATION & PLC ACHIEVES RECORD FULL YEAR ADJUSTED NET INCOME AND INVESTMENT GRADE LEVERAGE METRICS, REINSTATES DIVIDEND
with the covenants set forth in our debt agreements. We define adjusted EBITDA as adjusted net income (loss) adjusted for (i) interest, (ii) taxes and (iii) depreciation and amortization. There are material limitations to using adjusted EBITDA. Adjusted EBITDA does not take into account certain significant
More news about: Carnival Corporation & plc
Dec 19, 2025, 09:07 ET Syncarpha Capital Turns On First Community Solar Project In Maryland, SynerGen Panorama III, LLC
Syncarpha Capital, LLC announced that its first community solar project in Maryland, SynerGen Panorama III, LLC, has received Permission to Operate ("PTO"), officially bringing new, locally generated clean energy online for Baltimore Gas and Electric ("BGE")
More news about: Syncarpha Capital
Dec 19, 2025, 09:00 ET Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE
effective than defendants had led investors to believe; (ii) accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.WHAT'S NEXT? If you suffered a loss
More news about: Levi & Korsinsky
Dec 19, 2025, 09:00 ET FLY LAWSUIT ALERT: Levi & Korsinsky Notifies Firefly Aerospace Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the offering documents and defendants'
More news about: Levi & Korsinsky
Dec 19, 2025, 09:00 ET Investors who lost money on DexCom, Inc. (DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM
and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (iii) accordingly, defendants' purported enhancements to the G7, as well as the device's reliability, accuracy, and functionality, were overstated; (iv) defendants
More news about: Levi & Korsinsky
Dec 19, 2025, 09:00 ET Levi & Korsinsky Notifies DeFi Technologies Investors of a Class Action Lawsuit and Upcoming Deadline - DEFT
treasury companies and the extent to which that competition would negatively impact its ability to execute its DeFi arbitrage strategy; (iii) as a result of the foregoing issues, the Company was unlikely to meet its previously issued revenue guidance for the fiscal year 2025; (iv) accordingly,
More news about: Levi & Korsinsky